Objectives-To determine the characteristics of fetal ventricular septal defects (VSDs) that will be less likely to close prenatally.
C ongenital heart defects (CHDs) are the most common congenital anomalies affecting neonates (0.5%-0.8%). 1, 2 Ventricular septal defects (VSDs) are the most common CHDs in neonates (25%-30%). 3 First-trimester nuchal translucency screening and the second-trimester fetal anatomy survey have been performed more frequently, using high-resolution ultrasound equipment. Hence, isolated VSDs have been diagnosed more often in utero in both the low-and high-risk obstetric populations. Consequently, counseling of pregnant women carrying fetuses with a VSD has occurred more frequently. The prenatal course of a VSD has not been adequately studied, especially in the low-risk obstetric population. The prenatal resolution frequency of VSDs has been reported with a wide range of variations (5.3%-84%) in previous studies. [4] [5] [6] [7] The objective of this study was to determine the characteristics of VSDs that are associated with spontaneous closure in utero.
Materials and Methods
This retrospective cohort study examined fetuses with a diagnosis of a VSD (with or without associated cardiac defects) during a comprehensive fetal anatomy survey using 2-dimensional ultrasound with color and pulsed wave Doppler studies between January 1 2012, and December 31, 2015, at the Louisiana State University Health Sciences Center's maternal-fetal medicine clinics. We documented all ultrasound reports in the View Point 5 program for obstetrics and gynecology (GE Healthcare, Waukesha, WI). We used the Query function of the View Point Data Analytics to identify fetuses with VSDs in the studied period. We routinely performed a comprehensive fetal anatomy survey using color and pulsed wave Doppler studies in all pregnant women seen in our maternal-fetal medicine clinics regardless of the referral indications. All difficult cases such as membranous and complex cardiac defects were confirmed by 4-dimensional spatiotemporal image correlation volume studies. Women carrying these affected fetuses belonged to both low-and high-risk obstetric populations. A single examiner performed all studied comprehensive fetal anatomy surveys. Either 1 of 2 responsible pediatric cardiologists performed fetal echocardiography to confirm the VSD diagnosis. The VSDs were categorized as membranous, muscular, or both. These fetuses were followed monthly until their birth. They were all subsequently underwent postnatal echocardiography within 1 month of age to assess the persistence of a VSD. Women carrying these fetuses received prenatal genetic counseling. Some chose to have invasive prenatal diagnostic tests. Others opted for noninvasive prenatal testing (cell-free fetal DNA). All living neonates' karyotypes were confirmed postnatally.
The analyzed variables were the gestational age (GA) at diagnosis, the initial and maximal VSD sizes, the increasing trend of VSD sizes, VSD locations (muscular, membranous, or both), other cardiac defects, other fetal structural anomalies, fetal karyotypes, pregestational diabetes mellitus, and a family history of congenital cardiac defects. The Fisher exact test was used to examine associations between categorical variables, whereas the Wilcoxon rank sum test was used to compare quantitative variables between the prenatally closed VSD versus the persistently patent VSD. Bivariate and multivariate logistic regression analyses were used to model variables' associations with prenatal VSD closure. Variables with P .05 were included in the multivariable logistic regression model. The Hosmer and Lemeshow goodness-of-fit test was used to evaluate the fit of multivariable logistic regression models. The log rank test and a Kaplan-Meier curve were used to examine GAs at prenatal VSD closure between VSDs with a fixed size versus VSDs that increased in size in utero. SAS version 9.4 software (SAS Institute Inc, Cary, NC) was used for all data analyses except the Kaplan-Meyer curve. This graph was created by using the "survival" library in R version 3.2.4 software (R Foundation for Statistical Computing, Vienna, Austria). This study was approved by the Louisiana State University Health Sciences Center's, East Jefferson General Hospital's, Touro Hospital's, and Children Hospital's Institutional Review Boards.
Results
The Query function of the View Point 5 program identified 153 fetuses with a VSD (with or without associated cardiac defects; 3.74%) among 4090 pregnant women referred to the Louisiana State University Health Sciences Center's maternal-fetal medicine clinics in the studied period. In this study, VSDs were diagnosed at a mean GA 6 SD of 20.8 6 4.4 weeks. The median GA of the VSD diagnosis was 19.1 weeks. Five fetuses were lost to follow up. The mean age of pregnant women carrying a fetus with a VSD was 32.8 6 6.2 years. One hundred twenty-five of 148 affected fetuses (84.46%) had spontaneous prenatal VSD closure, whereas 23 of 148 (15.54%) did not. The mean GA at the spontaneous prenatal VSD closure was 26.9 6 4.5 weeks.
Potentially influencing factors were examined for associations with spontaneous prenatal VSD closure. There were 15 (10.14%) membranous and 126 (85.14%) muscular VSDs diagnosed in this study. In addition, 7 fetuses (4.73%) had both membranous and muscular VSDs at different cardiac locations. Thirteen of 15 membranous (86.67%) and 105 0f 126 muscular (83.33%) defects closed spontaneously in utero. All 7 fetuses having both VSD types at different cardiac locations also had prenatal closures of both VSDs. The VSD locations were not significantly different between the closure group versus the persistent VSD group (P 5 .698). The incidence of aneuploidy in fetuses with a diagnosis of a VSD was 9.46% (14 of 148). The aneuploidies included 5 (3.38%) trisomy 21, 5 (3.38%) trisomy 18, 1 trisomy 16, 1 trisomy 22, 1 triple X syndrome (or 47,XXX), and 1 DiGeorge or velocardiofacial syndrome. Nine of 23 fetuses (39.13%) in the persistent VSD group had an abnormal karyotype in contrast to only 5 of 125 (4.0%) in the prenatally closed VSD group (P < .001). Gestational age at diagnosis (P < .001), increasing VSD size (P 5 .050), initial VSD size (P 5 .002), maximal VSD size in utero (P < .001), associated cardiac defects (P < .001), extracardiac defects (P 5 .003), and abnormal karyotype (P < .001) had significant bivariate associations with prenatal VSD closure ( Table 1 ). All significant bivariate associations were fitted into the multivariate logistic regression model. The multivariate regression model had an adequate model fit (Hosmer and Lemeshow goodness-of-fit test, P 5 .378). This regression model also showed a statistically significant association with spontaneous prenatal VSD closure (P 5 .002), with an area under the receiver operating characteristic curve of 91.0% ( Figure 1 ). After controlling all potential variables in the multivariate logistic regression model, the presence of other cardiac defects (P 5 .0313) and an abnormal fetal karyotype (P 5 .0212) significantly reduced the likelihood of spontaneous VSD closure in utero (Table 2) . However, there were 5 fetuses with associated cardiac defects who developed a spontaneous prenatal VSD closure.
Fetus 55 was a male (46,XY) fetus with a diagnosis of a 2.9-mm muscular VSD and partial pulmonic valve stenosis at a GA of 26 weeks 5 days. He developed right ventricular hypertrophy at approximately 28 weeks. His VSD closed spontaneously at 30 weeks 5 days. He had intrauterine growth restriction and oligohydramnios. He was born at 33 weeks 5 days by cesarean delivery due to nonreassuring antenatal surveillance findings, with Apgar scores of 5 at 1 minute and 6 at 5 minutes and a birth weight of 1101 g.
Fetus 71 was a male (46,XY) fetus with a diagnosis of a 2.8-mm muscular VSD and partial aortic valve stenosis at a GA of 18 weeks 4 days. His VSD spontaneously closed at 24 weeks 4 days. He also developed left ventricular hypertrophy at approximately the same time. His mother gave birth to him at 34 weeks by cesarean delivery due to spontaneous preterm labor with a double-footling breech presentation. He had Apgar scores of 5 at 1 minute and 6 at 5 minutes and a birth weight of 1690 g.
Fetus 75 was a male (46,XY) fetus with a diagnosis of a 2.9-mm muscular VSD and a partial ductus arteriosus constriction at a GA of 19 weeks 5 days. His mother took only prenatal vitamins during pregnancy. He developed right ventricular hypertrophy at 24 weeks' gestation. His VSD closed spontaneously at 26 weeks 5 days. His mother gave birth to him at 31 weeks 6 days by cesarean delivery due to spontaneous preterm labor and nonreassuring antenatal surveillance findings. He had Apgar scores of 6 at 1 minute and 7 at 5 minutes and a birth weight of 1670 g.
Fetus 111 was a female (46,XX) fetus with a diagnosis of a 2.8-mm muscular VSD and a partial ductus Factors influencing the spontaneous prenatal closure of isolated VSDs are listed in Table 3 . An increasing VSD size in utero (P 5 .042) and an abnormal karyotype (P < .001) significantly reduced the likelihood of spontaneous prenatal closure of isolated VSDs.
Interestingly, all prenatally diagnosed VSDs with a maximal size of 2 mm or less closed spontaneously in utero (21 of 21 [100%]), whereas 104 of 127 VSDs (81.89%) with a maximal size of greater than 2 mm closed prenatally (P 5 .045). The maximal VSD size was significantly associated with the odds of spontaneous closure in utero, with an area under the receiver operating characteristic curve of 76.6% (P < .001).
In addition, 38 fetuses had VSDs that initially increased in size in utero. Twenty-nine of these 38 VSDs (76.3%) eventually closed prenatally. However, these VSDs closed at a median GA of 34.6 weeks, which was significantly later than the median GA of 26 weeks in the VSD group with a fixed size (P 5 .001; Figure 2) . In a bivariate analysis of the 38 fetuses whose VSDs increased in size in utero, the GA at delivery and the birth weight were significantly associated with prenatal closure. For every additional week in utero, the odds of prenatal closure more than doubled (odds ratio [OR] 5 2.239; 95% confidence interval [CI] 5 1.249-4.013; P 5 .007). For every 1-g increase in birth weight, the odds of prenatal closure increased by 0.2% (OR 5 1.002; 95% CI 5 1.000-1.004; P 5 .024).
The perinatal outcomes of neonates with a prenatal diagnosis of a VSD (with and without associated cardiac defects) are included in Table 4 . Fetuses with a persistent VSD were delivered at an earlier GA compared to those with a resolved VSD (P < .001). Consequently, the birth weight of neonates affected by a persistent VSD was significantly lower than that in the closure group's (P < .001).
Seven fetuses died in utero (Table 5) . Five fetuses had trisomy 18, and 1 had trisomy 22. Only 1 fetus had a normal karyotype and died of a large subchorionic hematoma.
Neonates with a persistent VSD had significantly lower Apgar scores at 1 minute (P < .001) and 5 minutes (P 5 .001). In this studied population, the perinatal complications (29 of 148 [19.59%]) included ]; P < .001). These women either delivered prematurely due to a spontaneous preterm birth or obstetrically indicated reasons such as intrauterine growth restriction, nonreassuring antenatal surveillance findings, severe preeclampsia, and others.
In the subset of women with a spontaneous (not iatrogenic) delivery, women with fetuses in the persistent VSD group still delivered before 37 weeks more frequently than women in the closure group (10 of We investigated what underlying factors influenced the pregnancy outcomes in women carrying fetuses with Data are presented as mean 6 SD and number (percent) where applicable. a Adjusted for type 1 and 2 maternal diabetes, maternal hypertension, fetal abnormal karyotypes, other fetal cardiac defects, fetal extracardiac defects, and preterm birth. Data are presented as mean 6 SD and number (percent) where applicable. a Adjusted for type 1 and 2 maternal diabetes, maternal hypertension, fetal abnormal karyotypes, other fetal cardiac defects, fetal extracardiac defects, and spontaneous preterm birth.
a persistent VSD. Multiple linear regression and logistic regression analyses were used to examine the association of prenatal VSD closure with quantitative and categorical perinatal outcomes, respectively. After controlling the effects of potentially influencing variables such as type 1 and 2 maternal diabetes, maternal hypertension, fetal aneuploidies, other cardiac defects, extracardiac defects, and spontaneous preterm births in the multivariate logistic regression analysis, neonates with a persistent VSD did not have significantly more perinatal complications than neonates with a prenatally closed VSD (Table 4 ). In the 38 neonates whose VSDs increased in size, the perinatal complications were not statistically different between the persistently patent VSD group versus the closure group after the multiple logistic regression analysis (Table 6 ). Hence, the persistence of a prenatal VSD by itself did not significantly increase the perinatal complications and, consequently, the perinatal morbidities. The fetuses whose VSDs were persistently patent in utero were probably intrinsically sicker than those in the VSD closure group. This factor might have led to the higher frequency of spontaneous preterm birth.
Discussion
This observational study probably was one of a few studies that followed fetuses with a VSD from the time of diagnosis at mid pregnancy until 1 month of age without therapeutic abortions in populations at low and high risk for congenital cardiac defects. In our study, 84% of prenatally diagnosed VSDs closed spontaneously in utero compared to 5.2% to 84% in previous studies. [4] [5] [6] [7] In our study, VSDs were diagnosed at an earlier GA (mean, 20.8 weeks; median, 19.1 weeks) compared to studies by G omez et al 6 (median, 30.4 weeks) and Paladini et al 5 (mean, 24.8 weeks). Therefore, those previous studies might have missed the already-closed VSDs, probably because of delayed echocardiograms. Most of our prenatally diagnosed VSDs were muscular (85.14%), similar to the study by G omez et al 6 (87.10%). According to that Barcelona study, a spontaneous VSD closure was significantly associated with the location of the defect and the VSD-to-aorta ratio. Their muscular VSDs were less likely to close prenatally compared to their perimembranous VSDs (OR, 0.385; 95% CI, 0.160-0.926; P 5 .03). Their small defects (VSD-to-aorta ratio <0.5) closed more frequently prenatally and postnatally (OR, 0.445; 95% CI, 0.216-0.914; P 5 .03). In the study by Paladini et al, 5 43.5% of perimembranous VSDs closed in utero. In a study by Erol et al, 8 83.8% of muscular VSDs of 3-mm or less closed spontaneously during gestation or the first year of life. In our study, all VSDs of 2 mm or less closed prenatally regardless of their locations. In addition, the VSD locations were not significantly associated with the prenatal closure in this study (P 5 .698).
The defects complicated by other cardiac anomalies or associated with an abnormal karyotype were less likely to close in utero in this study. The prevalence of abnormal karyotypes in our study was 9.46%, which was within the published prevalence range of 1.2% 6 to 26.6%. 5 The difference in the prevalence of aneuploidies could have been due to different studied populations. Furthermore, we investigated VSDs in both populations at low and high risk for congenital cardiac defects. According to a study by Mosimann et al, 9 no chromosomal abnormalities were identified in fetuses with a VSD who had normal nuchal translucency and no other ultrasound anomalies. In contrast, 51.4% of fetuses with an isolated VSD and associated extracardiac anomalies were euploid in a study by Axt-Fliedner et al. 10 Unfortunately, we could not analyze the association between normal nuchal translucency and prenatal VSD closure because most of the pregnant women carrying fetuses with a VSD were referred to our clinic in the second trimester. Unlike the study by Paladini et al, 5 which had a 41.2% rate of therapeutic abortions, our study had no therapeutic abortions. Consequently, we could observe the natural development of VSDs without a selective bias. Other studies only observed isolated VSDs [4] [5] [6] [7] ; however, we followed both isolated VSDs and those associated with other cardiac defects.
In addition, we detected a subset of VSDs whose sizes initially increased in utero; 76.3% of these VSDs eventually closed prenatally and at the later median GA of 34.6 weeks. Delaying the GA at delivery by every additional week would increase the odds of prenatal closure by a factor of 2.239. This information would be very useful in the care of more than three-fourths of fetuses whose VSDs increase in size.
The frequency of spontaneous preterm births (20.9%) in our study was higher than the 2016 March of Dimes rate of spontaneous preterm births (12.3%) in Louisiana. Our studied population probably had more maternal and perinatal morbidities. However, the persistence of a patent VSD by itself did not significantly increase the perinatal morbidities of our affected fetuses.
According to a study by Chiu et al, 11 fetuses with isolated VSDs had lower biometric values and lower birth weights than fetuses without VSDs. The pulsatility index values of the middle cerebral artery in fetuses with isolated VSDs were significantly lower than the values in fetuses without VSDs (P < .0001). Further studies will need to investigate these hemodynamic changes in fetuses with VSDs.
Our study was a retrospective cohort observational study. It had limitations such as the small sample size and an assessment bias or false-positive diagnosis. To decrease the assessment bias, the VSD diagnosis was confirmed by flow across the defect on color and pulsed wave color Doppler studies in all cases. All difficult cases such as membranous and combined defects were reviewed on 4-dimensional spatiotemporal image correlation volume studies. Fetuses with prenatal demise did not undergo autopsy because of a lack of funding and regional traditions.
However, to the best of our knowledge, this study probably was one of a few studies that followed fetuses with VSDs from the time of diagnosis at mid pregnancy until the first month of age in both low-and high-risk obstetric populations. Furthermore, this study not only predicted the likelihood of prenatal closure but also investigated the perinatal morbidity of these affected fetuses and neonates. This information will be helpful in counseling pregnant women carrying fetuses with a diagnosis of a VSD.
